Glycosidase-targeting small molecules for biological and therapeutic applications

Y Kim, H Li, J Choi, J Boo, H Jo, JY Hyun… - Chemical Society …, 2023 - pubs.rsc.org
Glycosidases are ubiquitous enzymes that catalyze the hydrolysis of glycosidic linkages in
oligosaccharides and glycoconjugates. These enzymes play a vital role in a wide variety of …

The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology

CJ Guerriero, JL Brodsky - Physiological reviews, 2012 - journals.physiology.org
Protein folding is a complex, error-prone process that often results in an irreparable protein
by-product. These by-products can be recognized by cellular quality control machineries …

Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders

G Parenti, G Andria, KJ Valenzano - Molecular Therapy, 2015 - cell.com
Lysosomal storage disorders (LSDs) are a group of inborn metabolic diseases caused by
mutations in genes that encode proteins involved in different lysosomal functions, in most …

GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies

AF Leal, E Benincore-Flórez, D Solano-Galarza… - International journal of …, 2020 - mdpi.com
GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside
accumulation into the lysosome due to mutations on the genes encoding for the β …

Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease

GHB Maegawa, MB Tropak, JD Buttner… - Journal of Biological …, 2009 - ASBMB
Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a
deficiency of glucocerebrosidase (GCase). The identification of small molecules acting as …

Clarifying lysosomal storage diseases

ML Schultz, L Tecedor, M Chang, BL Davidson - Trends in neurosciences, 2011 - cell.com
Lysosomal storage diseases (LSDs) are a class of metabolic disorders caused by mutations
in proteins critical for lysosomal function. Such proteins include lysosomal enzymes …

[HTML][HTML] Chemical and biological approaches synergize to ameliorate protein-folding diseases

TW Mu, DST Ong, YJ Wang, WE Balch, JR Yates… - Cell, 2008 - cell.com
Loss-of-function diseases are often caused by a mutation in a protein traversing the
secretory pathway that compromises the normal balance between protein folding, trafficking …

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics

G Parenti - EMBO molecular medicine, 2009 - embopress.org
Lysosomal storage diseases (LSDs) are a group of genetic disorders due to defects in any
aspect of lysosomal biology. During the past two decades, different approaches have been …

Pharmacological chaperones as therapeutics for lysosomal storage diseases

RE Boyd, G Lee, P Rybczynski… - Journal of medicinal …, 2013 - ACS Publications
Lysosomal enzymes are responsible for the degradation of a wide variety of glycolipids,
oligosaccharides, proteins, and glycoproteins. Inherited mutations in the genes that encode …

Advances in therapies for neurological lysosomal storage disorders

S Ellison, H Parker, B Bigger - Journal of Inherited Metabolic …, 2023 - Wiley Online Library
Abstract Lysosomal Storage Disorders (LSDs) are a diverse group of inherited, monogenic
diseases caused by functional defects in specific lysosomal proteins. The lysosome is a …